51% of COVID-19 patients report they experienced the loss of smell and taste up to five months after infection. On average, once their senses were restored, people reported a loss in sensitivity to smell and taste. Read More
A new, lasting consequence of COVID-19 infection has been identified. Researchers report they have identified significant abnormalities in the eyes of those with severe coronavirus infection. Read More
Almost 50% of people diagnosed with coronavirus report symptoms of depression following their diagnosis. Read More
Loneliness, stress, and social isolation as a result of COVID-19 exacerbated and intensified visual hallucinations in blind people with Charles Bonnet Syndrome by 56%. Read More
Trained scent detection dogs are able to detect organic compounds associated with COVID-19 in patients. Researchers report the dogs are better at detecting coronavirus infection than standard tests. Read More
Many patients report symptoms of "brain fog" and confusion as a result of COVID-19 infection. Researchers report inflammatory molecules in the cerebral spinal fluid could be the cause of brain fog associated with coronavirus. Anti-inflammatory drugs, such as steriods, could help alleviate the symptoms of COVID brain. Read More
··5 min read
A new AI system is not only able to analyze potential new variants of COVID-19, it can also vaccine design cycles within minutes, researchers report. Read More
··4 min read
Analyzing patient data, artificial intelligence technology was able to predict mortality risk from COVID-19 infection with 90% accuracy. Read More
Researchers say our dreams are reflecting fears and anxiety associated with the COVID-19 pandemic. Read More
ApoE4, a gene associated with an increased risk of Alzheimer's disease, also appears to increase susceptibility and the severity of COVID-19. SARS-CoV-2, the virus responsible for coronavirus, increased susceptibility to COVID-19 in ApoE4 neurons and astrocytes in brain organoid models. Read More
Melatonin produced in the lungs acts as a barrier defense against SARS-CoV-2, the virus that causes COVID-19, by blocking the expression of genes that encode proteins in cells acting as viral entry points. Read More
People with schizophrenia are 2.7 times more likely to die as a result of contracting coronavirus than other groups of people. Schizophrenia is second only to age in mortality risk for COVID-19 infection.The higher risk could not be explained by other risk factors associated with the mental health disorder, including smoking, heart disease, and diabetes. People with other mental health and anxiety disorders are not at increased risk of death associated with COVID-19. Read More
